Stocks and Investing Stocks and Investing
Mon, April 17, 2017

Madhu Kumar Reiterated (AKTX) at Strong Sell with Increased Target to $130 on, Apr 17th, 2017


Published on 2024-10-25 20:50:03 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Chardan Capital, Reiterated "Akari Therapeutics, Plc" (AKTX) at Strong Sell with Increased Target from $100 to $130 on, Apr 17th, 2017.

Madhu, nor any peers, have made any analyst calls on AKTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources